Investigational Site Number :7240003

Madrid / Madrid, Madrid, Comunidad de 28040

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma, Malignant Solid Tumor, Neoplasm, Oesophageal Adenocarcinoma, Oesophageal Squamous Cell Carcinoma

Studies at this site

• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) — Completed
• A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors — Completed
• Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies — Stopped early